Peter Sundström

6.6k total citations · 1 hit paper
82 papers, 3.5k citations indexed

About

Peter Sundström is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Peter Sundström has authored 82 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 18 papers in Immunology. Recurrent topics in Peter Sundström's work include Multiple Sclerosis Research Studies (52 papers), Polyomavirus and related diseases (14 papers) and Peripheral Neuropathies and Disorders (11 papers). Peter Sundström is often cited by papers focused on Multiple Sclerosis Research Studies (52 papers), Polyomavirus and related diseases (14 papers) and Peripheral Neuropathies and Disorders (11 papers). Peter Sundström collaborates with scholars based in Sweden, United Kingdom and United States. Peter Sundström's co-authors include Anders Svenningsson, Jonatan Salzer, Martin Gunnarsson, Markus Axelsson, Tomas Olsson, Clas Malmeström, Jan Lycke, Göran Hallmans, Göran Wadell and Fredrik Piehl and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Peter Sundström

80 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

2017 325 citations Henrik Zetterberg, Peter Sundström et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Sundström Sweden	29	2.5k	907	754	693	510	82	3.5k
Dana Horáková Czechia	33	2.4k 1.0×	806 0.9×	342 0.5×	351 0.5×	735 1.4×	153	3.3k
Lucia Moiola Italy	40	3.6k 1.5×	1.8k 2.0×	658 0.9×	789 1.1×	811 1.6×	160	4.9k
Andreas Lutterotti Austria	29	1.7k 0.7×	973 1.1×	805 1.1×	378 0.5×	512 1.0×	79	2.9k
Diego Franciotta Italy	38	2.4k 1.0×	2.7k 3.0×	778 1.0×	535 0.8×	882 1.7×	154	5.0k
Mauro Zaffaroni Italy	33	2.3k 0.9×	1.1k 1.2×	553 0.7×	554 0.8×	700 1.4×	130	3.4k
Orhun H. Kantarci United States	37	2.7k 1.1×	1.6k 1.7×	772 1.0×	401 0.6×	973 1.9×	133	4.8k
Scott D. Newsome United States	33	2.8k 1.1×	1.2k 1.3×	195 0.3×	362 0.5×	973 1.9×	168	4.4k
Patrice H. Lalive Switzerland	34	1.0k 0.4×	1.0k 1.1×	940 1.2×	321 0.5×	251 0.5×	140	3.3k
Vesna Brinar Croatia	22	2.6k 1.1×	1.2k 1.3×	576 0.8×	600 0.9×	781 1.5×	99	3.5k
Stephen Reddel Australia	35	1.2k 0.5×	1.8k 2.0×	403 0.5×	193 0.3×	847 1.7×	118	3.7k

Countries citing papers authored by Peter Sundström

Since Specialization

Citations

This map shows the geographic impact of Peter Sundström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sundström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sundström more than expected).

Fields of papers citing papers by Peter Sundström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sundström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sundström. The network helps show where Peter Sundström may publish in the future.

Co-authorship network of co-authors of Peter Sundström

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Sundström. A scholar is included among the top collaborators of Peter Sundström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Sundström. Peter Sundström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alonso-Magdalena, Lucía, Olga Carmona, Elisabet Zia, Peter Sundström, & Hélène Pessah-Rasmussen. (2024). Prevalence and disease disability in immigrants with multiple sclerosis in Malmö, southern Sweden. Clinical Neurology and Neurosurgery. 240. 108255–108255. 1 indexed citations

Biström, Martin, Jonatan Salzer, Pernilla Stridh, et al.. (2023). Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis. Brain. 147(1). 177–185. 13 indexed citations

Ahlm, Clas, et al.. (2023). Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption. Frontiers in Immunology. 14. 1219560–1219560. 2 indexed citations

Sundström, Peter, et al.. (2021). Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis. Journal of Neurology. 268(6). 2161–2168. 33 indexed citations

Forsberg, Lars, Anna Fält, Å. Berglund, et al.. (2019). Clinical effectiveness of dimethyl fumarate with focus on patients treated at least 36 months - a Swedish nationwide study of the long-term effectiveness and safety of dimethyl fumarate (IMSE5). Multiple Sclerosis Journal. 25. 316–317. 1 indexed citations

Fält, Anna, Å. Berglund, Jan Hillert, et al.. (2018). A Swedish nationwide pharmaco-epidemiological and genetic study of the long-term safety and effectiveness of dimethyl fumarate (IMSE 5). Multiple Sclerosis Journal. 24. 699–700. 4 indexed citations

Flon, Pierre de, Lars Söderström, Katarina Laurell, et al.. (2018). Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls. PLoS ONE. 13(2). e0192516–e0192516. 15 indexed citations

Røsjø, Egil, Andreas Lossius, Nada Abdelmagid, et al.. (2016). Effect of high-dose vitamin D ₃ supplementation on antibody responses against Epstein–Barr virus in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 23(3). 395–402. 46 indexed citations

Axelsson, Markus, Clas Malmeström, Martin Gunnarsson, et al.. (2013). Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis. Multiple Sclerosis Journal. 20(1). 43–50. 102 indexed citations

10.

Salzer, Jonatan, Martin Biström, & Peter Sundström. (2013). Vitamin D and multiple sclerosis: where do we go from here?. Expert Review of Neurotherapeutics. 14(1). 9–18. 16 indexed citations

11.

Bruzelius, Fredrik, et al.. (2012). Velocity Planning for a Racing Driver Model. Chalmers Publication Library (Chalmers University of Technology). 2 indexed citations

12.

Vågberg, Mattias, Khalid Ambarki, J. B. M. Warntjes, et al.. (2012). Automated Determination of Brain Parenchymal Fraction in Multiple Sclerosis. American Journal of Neuroradiology. 34(3). 498–504. 51 indexed citations

13.

Simon, KG, Ingrid van der Mei, Anne‐Louise Ponsonby, et al.. (2010). Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology. 74(17). 1365–1371. 103 indexed citations

14.

Sundström, Peter, Mats Jonasson, Johan Andréasson, Annika Stensson Trigell, & Bengt Jacobson. (2010). Path and control signal optimisation for over-actuated vehicles in two safety-critical maneuvers. Chalmers Publication Library (Chalmers University of Technology). 13 indexed citations

15.

Sundström, Peter, Maria Nyström, Kristina Ruuth, & Erik Lundgren. (2009). Antibodies to specific EBNA-1 domains and HLA DRB1⁎1501 interact as risk factors for multiple sclerosis. Journal of Neuroimmunology. 215(1-2). 102–107. 81 indexed citations

16.

Mei, Ingrid van der, Anne‐Louise Ponsonby, Joanne L. Dickinson, et al.. (2008). Smoking as an independent risk factor for multiple sclerosis: considering possible combined effects with the human leukocyte antigen DR15 genotype and anti-EBNA antibody titers. eCite Digital Repository (University of Tasmania). 1 indexed citations

17.

Sundström, Peter, L. Nyström, & Göran Hallmans. (2008). Smoke exposure increases the risk for multiple sclerosis. European Journal of Neurology. 15(6). 579–583. 77 indexed citations

18.

Nyström, Maria, Kristina Ruuth, Erik Lundgren, & Peter Sundström. (2007). No support for a truncated interferon‐α17 allele as risk factor for MS. European Journal of Neurology. 14(11). 1302–1304. 2 indexed citations

19.

Sundström, Peter. (2004). Clinical characteristics of multiple sclerosis in Vasterbotten County in northern Sweden. Journal of Neurology Neurosurgery & Psychiatry. 75(5). 711–716. 18 indexed citations

20.

Sundström, Peter. (2002). Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Vasterbotten County in northern Sweden. Journal of Neurology Neurosurgery & Psychiatry. 74(1). 29–32. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact